🎙 ICYMI: Interested in learning more about the future of #pathology? In this podcast with ConcertAI, PathAI CEO Andrew Beck details how #AI & #digitalpathology will transform #RealWorldData, drug development, and the future of #healthtech. Listen to the #podcast or read the transcript: https://lnkd.in/eATsuzeE Learn more about Real-World Data: https://lnkd.in/eT6-ti8j #RWD #RWE #biotech #drugdevelopment #clinicaldevelopment #healthtech
PathAI
Software-Entwicklung
Boston, Massachusetts 54,069 followers
Improving patient outcomes with AI-powered pathology.
Über uns
PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ's Best Places to Work!
- Website
-
http://www.pathai.com
External link for PathAI
- Industrie
- Software-Entwicklung
- Größe des Unternehmens
- 501-1,000 employees
- Hauptsitz
- Boston, Massachusetts
- Typ
- In Privatbesitz
- Gegründet
- 2016
- Spezialitäten
- artificial intelligence, pathology, digital pathology, oncology, immuno-oncology, auto immune disease, neurodegenerative disease, companion diagnostics, precision medicine, solutions, R&D, computational pathology, deep learning, software engineering, AI, Machine Learning, IBD, and cancer research
Standorte
-
Primäre
1325 Boylston St
Suite 10000
Boston, Massachusetts 02215, US
-
3495 Hacks Cross Rd
Memphis, Tennessee 38125, US
Employees at PathAI
Aktualisierungen
-
PathAI reposted this
PathAI's latest blog post explores the benefits labs can expect from adopting a comprehensive digital and AI strategy, underscoring the importance of these advancements in improving diagnostic accuracy, efficiency, and patient outcomes. Key benefits discussed include: 📈 Enhancing Diagnostic Accuracy and Consistency ⏩ Streamlining Workflow and Increasing Efficiency 🔬 Supporting Precision Medicine 💡 Fostering Innovation and Research 🌟 Supporting Better Patient Outcomes ✅ Follow the link below to read the article in full: https://lnkd.in/gQBGBQfG #digitalpathology #pathologynews
-
🔎 Discover how integrating digital #technology and #AI is revolutionizing #pathology. Our latest blog post explores the benefits labs can expect from adopting these strategies, from enhancing diagnostic accuracy to streamlining workflows. Read the full blog post here: https://lnkd.in/g3AfZaVk #Pathology #AI #DigitalPathology #Biotech #Biotechnology
-
🗓 Happening Today: 🔥 Kick off summer with a #FiresideChat on #DigitalPathology featuring our CEO, Andrew Beck! Join Andy and an incredible lineup of #GoogleCloud experts, partners, and customers at the #Healthcare and #LifeSciences #SummerCamp. They'll dive into the latest #HealthTech #AI trends. https://lnkd.in/ecV5VK_R Sign up today to hear Andy’s discussion today, July 24th at 1:00 PM ET to discover how PathAI is leveraging cutting-edge #AI technology to revolutionize #Pathology, #DrugDevelopment, #Oncology, #IBD, and #LiverDisease research.
-
PathAI reposted this
📆 TODAY is the day! Join me to learn more about the future of AI in healthcare. I'll be joined by experts from Amazon Web Services (AWS), PathAI, Pieces, and CareJourney, and together we will discuss where healthcare organizations are making progress, the challenges they still face, and how you can break through barriers to accelerate your implementation of AI and genAI. 👇 Register now to join the conversation at 2pm EDT/11am PDT. See you there! #genai #ai #cloud #datamanagement #healthcare #patientexperience #futureofhealthcare #valuebasedcare #genaiinhealthcare #aiinhealthcare #employeeexperience #physicianburnout
-
🌐 Partner with us to unlock the full value of your #realworlddata: Are you ready to enrich your real-world data (#RWD) with #AI-powered #pathology? We’re here to help! https://lnkd.in/emDrWPSC 1. Access Comprehensive RWD Datasets - Partner with PathAI and our industry-leading RWD collaborators, including Aster Insights and ConcertAI. Gain access to curated #multimodal datasets, encompassing clinical, molecular, and AI-powered pathology data. These datasets cover most oncology indications to help you drive innovation across the drug development lifecycle. 2. Enrich Your Existing RWD Cohorts - Transform your pathology whole slide images (WSIs) into actionable insights with PathAI’s AI-powered pathology solutions. Our tools extract standardized and structured tissue and cell data, enhancing your ability to characterize samples and drive discoveries in translational research and #clinicaldevelopment. 3. License AI-Powered Pathology Data Linked to TCGA - Free for academic users! Apply today to accelerate your research. https://lnkd.in/gzGGN3_9 Reach out to us: [email protected] #RealWorldData #biotech #translationalresearch #drugdevelopment #RealWorldEvidence #RWE #biotechnology #multimodaldata #healthtech #genomics #DNA #RNA #ClinicalData
-
We're pleased to be named to Boston Business Journal's list of the largest #HealthTech companies in Massachusetts alongside some of the area's other finest innovators! #Pathology #AI https://lnkd.in/ezEaUcYd
-
PathAI reposted this
Read PathAI's new blog on Real-World Data (RWD) and its impact on healthcare research and drug development. RWD, derived from routine patient care data such as electronic health records (EHRs), claims, and molecular testing, offers a broader and more diverse dataset than randomized controlled trials (RCTs), which are often limited by sample size, narrow inclusion criteria, and high costs. The integration of RWD with RCT data enhances insights into patient outcomes, treatment effectiveness, and disease progression, making the drug development process more cost-effective and informative. Researchers now use RWD throughout the drug development lifecycle, from identifying biomarkers to improving clinical trial design and supporting regulatory submissions. However, the unstructured nature of data in EHRs and other systems often limits RWD's potential. Advancements in digital pathology and AI-driven image analysis, such as PathAI’s AI-powered tools, are transforming pathology data into structured insights. This integration of quantitative histopathology data with clinico-genomic RWD enables comprehensive understanding of diseases at molecular, cellular, histological, and anatomical levels, advancing precision medicine and improving global healthcare outcomes. View the full article on Pathology News: https://lnkd.in/eeK2_fk2 #pathologynews #digitalpathology
-
🌐 Real-World Data that includes #clinical, #molecular, and #pathology data has a unique ability to drive innovation throughout the #drugdevelopment lifecycle. With these #multimodal datasets, researchers and drug developers can gain deeper insights into disease mechanisms, #biomarker strategies, and novel therapeutic targets through comprehensive, multi-scale analyses; ultimately making drug development faster and more cost-effective to improve patient outcomes. There are many different data modalities that can be utilized to accelerate research and #drugdevelopment. In our latest #blog, we dive into the unique benefits each of these modalities offer: https://lnkd.in/e3at47wQ Key Components of #RWD: 🔍 Pathology Data: Advances in #digitalpathology and AI, like PathAI’s PathExplore™, turn routine pathology samples into rich, quantitative cell and tissue insights. 💊 Clinical Data: Clinical RWD captures the complete patient journey, including treatment patterns, adverse events, and #patient outcomes. 🧬 Molecular Data: Genomic, transcriptomic, and proteomic data provides a comprehensive picture of disease mechanisms and biomarker signatures. Are you ready to unlock and boost your real-world data with #AI-powered pathology? Learn more about the power of AI-powered pathology + RWD and view our resources: https://lnkd.in/e8KH6Fzz #RealWorldData #biotech #translationalresearch #drugdevelopment #multimodal #RWD #BigData #MachineLearning #AI #DeepLearning #Healthtech #biopharma PathExplore™ is for research use only. Not for use in diagnostic procedures.
-
🌐 Real-world data (#RWD) is revolutionizing #healthcare research, #biomarker discovery, #drugdevelopment and more. But RWD has traditionally lacked a crucial data modality: 𝘩𝘪𝘴𝘵𝘰𝘱𝘢𝘵𝘩𝘰𝘭𝘰𝘨𝘺. In our latest blog, we detail how #pathology can be enhanced with #AI and paired with clinico-genomic RWD to unlock powerful new disease insights. Read the blog 📝 https://lnkd.in/eA8zf7dg Despite its importance, the size and complexity of pathology data have made it difficult to analyze quantitatively at scale. However, advancements in #digitalpathology and AI-driven tools are transforming this landscape. By converting unstructured whole slide images into structured data outputs, pathology can be seamlessly integrated with clinico-genomic RWD to deliver even richer multimodal patient cohorts. Whether you are a pathologist, researcher, or simply curious about the intersection of data science and healthcare, read our latest blog to learn more about applications and opportunities for AI-powered pathology in RWD. Learn more about the power of AI-powered pathology RWD and view our resources: https://lnkd.in/e8KH6Fzz #RealWorldData #biotech #translationalresearch #drugdevelopment #precisionmedicine #genomics #DNA #transcriptomics #cancerresearch #realworlddata #RWD